These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6241500)

  • 21. Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia.
    Hock CE; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1986 Mar; 122(2):213-9. PubMed ID: 3011442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
    Viehman GE; Ma XL; Lefer AM
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):651-6. PubMed ID: 1966110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
    Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
    Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
    Tsao PS; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
    Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
    Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane synthase inhibition and thromboxane/endoperoxide receptor antagonism in a chronic canine model of coronary thrombosis.
    Fitzgerald DJ; Fragetta J; Fenelon LC; FitzGerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():496-500. PubMed ID: 2959103
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Smith EF; Griswold DE; Egan JW; Hillegass LM; DiMartino MJ
    J Cardiovasc Pharmacol; 1989 May; 13(5):715-22. PubMed ID: 2472519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.
    Huzoor-Akbar ; Mukhopadhyay A; Anderson KS; Navran SS; Romstedt K; Miller DD; Feller DR
    Biochem Pharmacol; 1985 Mar; 34(5):641-7. PubMed ID: 3156599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradykinin-induced vasoconstriction of rat mesenteric arteries precontracted with noradrenaline.
    Fasciolo JC; Vargas L; Lama MC; Nolly H
    Br J Pharmacol; 1990 Oct; 101(2):344-8. PubMed ID: 2147865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
    Chan CC; Nathaniel DJ; Yusko PJ; Hall RA; Ford-Hutchinson AW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):276-82. PubMed ID: 6423813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.
    Smith EF; Lefer AM
    Am Heart J; 1981 Apr; 101(4):394-402. PubMed ID: 7211667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
    Fiedler VB; Seuter F; Perzborn E
    Stroke; 1990 Dec; 21(12 Suppl):IV149-51. PubMed ID: 2260140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist.
    Hall RA; Rokach JR; Bélanger P; Bianchi L; Ethier D; Ford-Hutchinson AW; Girard Y; Hamel P; Hamel R; Lord A
    Can J Physiol Pharmacol; 1987 Apr; 65(4):509-14. PubMed ID: 3607600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
    Lefer AM; Mentley R; Sun JZ
    Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.